SBI Securities’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$733 Buy
388
+331
+581% +$2.49K ﹤0.01% 2982
2026
Q2
$829 Buy
+57
New +$728 ﹤0.01% 2868
2025
Q4
– Sell
-2
Closed -$15 – 4218
2025
Q3
$15 Buy
+2
New +$12 ﹤0.01% 3968
2025
Q1
– Sell
-5
Closed -$31 – 4200
2024
Q4
$31 Buy
+5
New +$24 ﹤0.01% 3743

Other funds holding TENX

SBI Securities's TENX Position: Q3 2026 in Review

SBI Securities increased its Tenax Therapeutics (TENX) stake by 581% in Q3 2026, buying an estimated $2.49K and bringing the position to 388 shares worth $733. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

SBI Securities first reported a position in TENX in Q4 2024 and has held it in 4 quarters since. The position peaked at $829 in Q2 2026. 7 funds tracked by Wall St. Rank hold TENX as of Q3 2026.

  • SBI Securities held 388 shares of Tenax Therapeutics worth $733 as of Q3 2026.
  • SBI Securities bought 331 Tenax Therapeutics shares in Q3 2026, an estimated $2.49K.
  • Tenax Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2982 holding.
  • SBI Securities first reported a position in Tenax Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • SBI Securities's Tenax Therapeutics position peaked at $829 in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.